Sangeeta Bhatia, M.D., Ph.D.
Massachusetts Institute of Technology
Dr. Bhatia is a Howard Hughes Medical Institute Investigator and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS). She is a member of the Koch Institute for Integrative Cancer Research, the Ludwig Center for Molecular Oncology, and the Harvard Stem Cell Institute, an Institute Member of the Broad Institute, and a Biomedical Engineer at the Brigham & Women's Hospital. Trained as both a physician and engineer, Bhatia’s laboratory is dedicated to leveraging the ‘tiny technologies’ of miniaturization tools from the world of semiconductor manufacturing to impact human health. She has pioneered technologies for interfacing living cells with synthetic systems, enabling new applications in tissue regeneration, stem cell differentiation, medical diagnostics and drug delivery. Bhatia’s findings have produced high-throughput-capable human microlivers, which model human drug metabolism, drug-induced liver disease, and interaction with human pathogens. Her group also develops nanoparticles and nanoporous materials that can be designed to assemble and communicate to diagnose and treat a variety of diseases, including cancer.
Dr. Bhatia holds a B.S. from Brown University; an M.S. in mechanical engineering from MIT; a Ph.D. in biomedical engineering from MIT; and an M.D. from Harvard Medical School. She is an elected Fellow of the National Academy of Engineering, American Academy of Arts and Science, and National Academy of Inventors. She has been awarded the 2015 Heinz Award for Technology, Economy and Employment and the 2014 Lemelson-MIT Prize for Invention. As a passionate mentor and advocate for diversity in science and engineering, she has been the recipient of the Harvard Medical School Diversity Award and the Harvard-MIT Thomas McMahon Mentoring Award. She co-authored the first undergraduate textbook on tissue engineering and is a frequent advisor to governmental organizations on nanobiotechnology, biomedical microsystems, and regenerative medicine.